Nuclear oncology 2: Scintigrahic imaging

Razi Muzaffar, Osama Raslan, Medhat M. Osman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Nuclear medicine has a major role in the management of malignant tumors. With the developments towards molecular imaging and the technological advancement of scanners providing a fusion of both physiologic and anatomic imaging, it has even become a more integral part of management protocols. This role includes detection of malignant tumors, staging and restaging of the disease, early detection of recurrence, evaluation of the response to therapy, and prediction of the prognosis. Radionuclide diagnosis and therapy for tumors depend on the characteristics of tumors including increased vascularization, increased blood fl ow, newly proliferated capillaries with more permeable walls, increased metabolic activity of cells, increased energy demand, high density of some common antigens or several specifi c antigens, and several specifi c receptors as discussed in the previous chapter.

Original languageEnglish (US)
Title of host publicationThe Pathophysiologic Basis of Nuclear Medicine
PublisherSpringer International Publishing
Pages369-399
Number of pages31
ISBN (Electronic)9783319061122
ISBN (Print)9783319061115
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Nuclear oncology 2: Scintigrahic imaging'. Together they form a unique fingerprint.

  • Cite this

    Muzaffar, R., Raslan, O., & Osman, M. M. (2015). Nuclear oncology 2: Scintigrahic imaging. In The Pathophysiologic Basis of Nuclear Medicine (pp. 369-399). Springer International Publishing. https://doi.org/10.1007/978-3-319-06112-2_12